[Diuretic therapy in heart failure]

Med Clin (Barc). 2014 Feb 20;142(4):163-70. doi: 10.1016/j.medcli.2013.04.027. Epub 2013 Jun 12.
[Article in Spanish]

Abstract

Many of the primary clinical manifestations of heart failure (HF) are due to fluid retention, and treatments targeting congestion play a central role in HF management. Diuretic therapy remains the cornerstone of congestion treatment, and diuretics are prescribed to the majority of HF patients. Despite this ubiquitous use, there is limited evidence from prospective randomized studies to guide the use of diuretics. With the chronic use of diuretic and usually in advanced stages of HF, diuretics may fail to control salt and water retention. This review describes the mechanism of action of available diuretic classes, reviews their clinical use based on scientific evidence and discusses strategies to overcome diuretic resistance.

Keywords: Congestive Heart Failure; Diuretics; Diuréticos; Heart failure; Insuficiencia Cardiaca Congestiva; Insuficiencia cardiaca.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Carbonic Anhydrase Inhibitors / adverse effects
  • Carbonic Anhydrase Inhibitors / pharmacokinetics
  • Carbonic Anhydrase Inhibitors / therapeutic use
  • Diuresis / drug effects
  • Diuretics / adverse effects
  • Diuretics / classification
  • Diuretics / pharmacokinetics
  • Diuretics / therapeutic use*
  • Diuretics, Potassium Sparing / adverse effects
  • Diuretics, Potassium Sparing / pharmacokinetics
  • Diuretics, Potassium Sparing / therapeutic use
  • Drug Resistance
  • Evidence-Based Medicine
  • Heart Failure / drug therapy*
  • Humans
  • Natriuresis / drug effects
  • Randomized Controlled Trials as Topic
  • Sodium Chloride Symporter Inhibitors / adverse effects
  • Sodium Chloride Symporter Inhibitors / pharmacokinetics
  • Sodium Chloride Symporter Inhibitors / therapeutic use
  • Sodium Potassium Chloride Symporter Inhibitors / adverse effects
  • Sodium Potassium Chloride Symporter Inhibitors / pharmacokinetics
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use

Substances

  • Carbonic Anhydrase Inhibitors
  • Diuretics
  • Diuretics, Potassium Sparing
  • Sodium Chloride Symporter Inhibitors
  • Sodium Potassium Chloride Symporter Inhibitors